ARCHIVES

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Fox Chase Joins Plan For Free Cancer Screening

May 9, 1986

NCI-Approved Clinical Trials

March 31, 2006

In Congress: Senate Committee Provides Increase To DOD Program

August 1, 1997

Hatch Committee Clears Bill Blocking OMB Micromanagement

August 15, 1986

NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training

November 27, 1998

ASCO Briefing Highlights Seven Studies That Could Change Clinical Practice

May 29, 2009